作为潜在的TNF调节剂的酸,酸和酸酸:结合分子对接,动力学模拟,ADMET分析和基因表达分析的综合研究
Adolat Manakbayeva1, Andrey Bogoyavlenskiy1, Timur Kerimov1
1Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan.
Molecules (Basel, Switzerland)
|August 14, 2025
概括
有机酸,如酸,酸和酸酸被研究为瘤坏死因子 (TNF) 的调节剂. 酸和酸抑制了TNF,而克罗西刺激了它,揭示了复杂的抗炎潜力.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有机酸是影响人类健康的重要代谢物.
- 瘤坏死因子 (TNF) 是炎症的关键媒介,也是重要的治疗点.
研究的目的:
- 评价有机酸作为瘤坏死因子 (TNF) 的潜在调节剂.
- 研究酸,酸和酸酸的抗炎性质,以TNF为点.
主要方法:
- 采用了in silico分子对接和分子动力学 (MD) 模拟.
- 通过ADMET分析,评估了药物动力学特性.
- 在体内小鼠白细胞模型中评估了TNF基因表达.
主要成果:
- 克罗塞丁表现出预测最高的TNF结合亲和力,而酸显示出最稳定的复合物.
- 对ADMET的分析表明了潜在的药物动力学限制,例如低透性.
- 在体内研究显示,酸和酸抑制了TNF,而克罗西则刺激了TNF.
结论:
- 有机酸与TNF表现出复杂的相互作用,作为抑制剂或刺激剂.
- 酸和酸显示出作为TNF抑制剂的潜力,用于抗炎症应用.
- 需要进一步的研究来克服药理动力学挑战,并开发这些化合物用于TNF介导疾病.
更多相关视频
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
1.9K
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
8.6K
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
232
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
232
